CHINA PHARMA HOLDINGS, INC. Annual Cost of Revenue in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
China Pharma Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
  • China Pharma Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $1.62M, a 20.5% decline year-over-year.
  • China Pharma Holdings, Inc. annual Cost of Revenue for 2023 was $7.29M, a 15.2% decline from 2022.
  • China Pharma Holdings, Inc. annual Cost of Revenue for 2022 was $8.6M, a 7.48% decline from 2021.
  • China Pharma Holdings, Inc. annual Cost of Revenue for 2021 was $9.29M, a 4.25% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.29M -$1.31M -15.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $8.6M -$695K -7.48% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $9.29M +$379K +4.25% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $8.91M -$528K -5.59% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $9.44M -$914K -8.83% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 $10.4M -$388K -3.61% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $10.7M -$1.61M -13% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $12.4M -$3.43M -21.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $15.8M -$1.44M -8.35% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $17.2M -$6.19M -26.4% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $23.4M -$15.3M -39.5% Jan 1, 2013 Dec 31, 2013 10-K/A 2015-12-28
2012 $38.7M -$13.5M -25.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-20
2011 $52.2M +$8.07M +18.3% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-14
2010 $44.1M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.